These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 34746028)

  • 41. Association between angiotensin-converting enzyme-2 gene polymorphism (rs2106809) with severity and outcome of COVID-19 infection.
    Mohammadi-Berenjestanaki H; Mohammadali E; Khasayesi M; Rafiei A; Kashi Z; Mirzaei-Ilali N; Hosseini-Khah Z
    Mol Biol Rep; 2023 Aug; 50(8):6669-6679. PubMed ID: 37368197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
    Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
    Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
    Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of angiotensin-converting enzyme 2 (
    Fawzy MS; Ashour H; Shafie AAA; Dahman NBH; Fares AM; Antar S; Elnoby AS; Fouad FM
    Egypt J Med Hum Genet; 2022; 23(1):97. PubMed ID: 37521836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19.
    Talebi T; Masoumi T; Heshmatzad K; Hesami M; Maleki M; Kalayinia S
    Genet Res (Camb); 2023; 2023():2593199. PubMed ID: 38074420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.
    Adimulam T; Arumugam T; Gokul A; Ramsuran V
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating angiotensin converting enzyme 2 and COVID-19.
    Leowattana W; Leowattana T; Leowattana P
    World J Clin Cases; 2022 Dec; 10(34):12470-12483. PubMed ID: 36579082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity.
    Getachew B; Tizabi Y
    J Med Virol; 2021 Sep; 93(9):5285-5294. PubMed ID: 33990955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host factors: Implications in immunopathogenesis of COVID-19.
    Jafarpour R; Pashangzadeh S; Dowran R
    Pathol Res Pract; 2021 Dec; 228():153647. PubMed ID: 34749207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population.
    Sidhwani SK; Mirza T; Khatoon A; Shaikh F; Khan R; Shaikh OA; Nashwan AJ
    Virol J; 2023 Jun; 20(1):120. PubMed ID: 37308887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants.
    Shoily SS; Ahsan T; Fatema K; Sajib AA
    Infect Genet Evol; 2021 Aug; 92():104888. PubMed ID: 33933634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.
    Najafi M; Mahdavi MR
    Mol Genet Genomics; 2023 Jan; 298(1):27-36. PubMed ID: 36255490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic Landscape of the ACE2 Coronavirus Receptor.
    Yang Z; Macdonald-Dunlop E; Chen J; Zhai R; Li T; Richmond A; Klarić L; Pirastu N; Ning Z; Zheng C; Wang Y; Huang T; He Y; Guo H; Ying K; Gustafsson S; Prins B; Ramisch A; Dermitzakis ET; Png G; Eriksson N; Haessler J; Hu X; Zanetti D; Boutin T; Hwang SJ; Wheeler E; Pietzner M; Raffield LM; Kalnapenkis A; Peters JE; Viñuela A; Gilly A; Elmståhl S; Dedoussis G; Petrie JR; Polašek O; Folkersen L; Chen Y; Yao C; Võsa U; Pairo-Castineira E; Clohisey S; Bretherick AD; Rawlik K; ; ; Esko T; Enroth S; Johansson Å; Gyllensten U; Langenberg C; Levy D; Hayward C; Assimes TL; Kooperberg C; Manichaikul AW; Siegbahn A; Wallentin L; Lind L; Zeggini E; Schwenk JM; Butterworth AS; Michaëlsson K; Pawitan Y; Joshi PK; Baillie JK; Mälarstig A; Reiner AP; Wilson JF; Shen X
    Circulation; 2022 May; 145(18):1398-1411. PubMed ID: 35387486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shared genetics and causal association between plasma levels of SARS-CoV-2 entry receptor ACE2 and Alzheimer's disease.
    Zhang Y; Xu F; Wang T; Han Z; Shang H; Han K; Zhu P; Gao S; Wang X; Xue Y; Huang C; Chen Y; Liu G
    CNS Neurosci Ther; 2024 Jul; 30(7):e14873. PubMed ID: 39056224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asthma and COVID-19 pandemic: focus on the eosinophil count and ACE2 expression.
    Kanannejad Z; Alyasin S; Esmaeilzadeh H; Nabavizadeh H; Amin R
    Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):284-289. PubMed ID: 34503323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of genetic variants and host polymorphisms on COVID-19: From viral entrance mechanisms to immunological reactions.
    Adli A; Rahimi M; Khodaie R; Hashemzaei N; Hosseini SM
    J Med Virol; 2022 May; 94(5):1846-1865. PubMed ID: 35076118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets.
    Sodhi PV; Sidime F; Tarazona DD; Valdivia F; Levano KS
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.
    Zabihi Rizi F; Ghorbani A; Zahtab P; Darbaghshahi NN; Ataee N; Pourhamzeh P; Hamzei B; Dolatabadi NF; Zamani A; Hooshmand M
    Arch Virol; 2023 Mar; 168(4):119. PubMed ID: 36959416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE2 polymorphisms impact COVID-19 severity in obese patients.
    Jalaleddine N; Bouzid A; Hachim M; Sharif-Askari NS; Mahboub B; Senok A; Halwani R; Hamoudi RA; Al Heialy S
    Sci Rep; 2022 Dec; 12(1):21491. PubMed ID: 36513710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.